- Home
- HSII vs ARDX Comparison
HSII vs ARDX Comparison
Compare HSII & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSII
- ARDX
- Stock Information
- Founded
- HSII 1953
- ARDX 2007
- Country
- HSII United States
- ARDX United States
- Employees
- HSII N/A
- ARDX N/A
- Industry
- HSII Diversified Commercial Services
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- HSII Consumer Discretionary
- ARDX Health Care
- Exchange
- HSII Nasdaq
- ARDX Nasdaq
- Market Cap
- HSII 904.6M
- ARDX 882.9M
- IPO Year
- HSII 1999
- ARDX 2014
- Fundamental
- Price
- HSII $46.30
- ARDX $4.29
- Analyst Decision
- HSII Buy
- ARDX Strong Buy
- Analyst Count
- HSII 2
- ARDX 9
- Target Price
- HSII $49.00
- ARDX $10.17
- AVG Volume (30 Days)
- HSII 122.7K
- ARDX 4.3M
- Earning Date
- HSII 08-04-2025
- ARDX 08-04-2025
- Dividend Yield
- HSII 1.30%
- ARDX N/A
- EPS Growth
- HSII N/A
- ARDX N/A
- EPS
- HSII 0.37
- ARDX N/A
- Revenue
- HSII $1,116,954,000.00
- ARDX $361,706,000.00
- Revenue This Year
- HSII $6.41
- ARDX $11.39
- Revenue Next Year
- HSII $2.65
- ARDX $32.84
- P/E Ratio
- HSII $126.09
- ARDX N/A
- Revenue Growth
- HSII 6.10
- ARDX 127.33
- 52 Week Low
- HSII $34.67
- ARDX $3.21
- 52 Week High
- HSII $49.02
- ARDX $7.18
- Technical
- Relative Strength Index (RSI)
- HSII 53.19
- ARDX 51.49
- Support Level
- HSII $45.31
- ARDX $4.27
- Resistance Level
- HSII $47.30
- ARDX $4.48
- Average True Range (ATR)
- HSII 1.08
- ARDX 0.19
- MACD
- HSII -0.21
- ARDX -0.03
- Stochastic Oscillator
- HSII 26.68
- ARDX 15.84
About HSII Heidrick & Struggles International Inc.
Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments include the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.